Kezar Life Sciences, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
KZR on Nasdaq
Location
4000 Shoreline Court, Suite 300, South San Francisco, CA

Insiders trading volume in the past year

Kezar Life Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $1.75M Aug 15, 2023
Christopher J. Kirk CEO, Director $388K Nov 8, 2023
Mark C. Schiller Chief Legal Officer $19.1K -$3.88K -16.8% Jul 2, 2024
Micki Klearman Director Jun 20, 2024
Jason Dinges Director Jun 28, 2021
Courtney Wallace Director Jun 20, 2024
John Franklin Fowler CEO, Director Jul 24, 2023
Nicholas Michael Mordwinkin Chief Business Officer Jan 7, 2024
Franklin M. Berger Director Jun 20, 2024
Jean-Pierre Sommadossi Director Jun 28, 2021
Elizabeth Garner Director Jun 20, 2024
Michael Kauffman Director Jun 20, 2024
Graham K. Cooper Director Jun 20, 2024
Marc Belsky Chief Financial Officer Jan 7, 2024
Noreen Henig Chief Medical Officer Jul 24, 2023

Recent Insider Transactions by Companies or Individuals for Kezar Life Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.